Itron's $525M deal for Locusview expands its digital construction tools even as utilities slow spending amid macro uncertainty.
The B-FREE Chronic Babesiosis Study ( NCT06656351) is a Phase 2 open-label study that will evaluate the efficacy (and safety) of the ARAKODA ® regimen of tafenoquine over 90 days for resolution of ...
Digiarty's VideoProc Converter AI can enhance your old, grainy, shaky, and low resolution video by using AI to enhance it and ...
Mobile Wage Access Apps Market reached USD 3.20 billion in 2024 and is expected to rise to USD 66.76 billion by ...
DoorDash stands out as a resilient growth story amid restaurant sector weakness, despite its recent 30% stock correction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results